Shardul Amarchand Mangaldas & Co. advised the Underwriters on Niva Bupa Health Insurance Company’s initial public offering

Shardul Amarchand Mangaldas & Co. advised the Underwriters, viz., ICICI Securities Limited, Morgan Stanley India Company Limited, Kotak Mahindra Capital Company Limited, Axis Capital Limited, HDFC Bank Limited and Motilal Oswal Investment Advisors Limited on Niva Bupa Health Insurance Company Limited’s (“Company”) USD 260 million initial public offering of equity shares.   The IPO comprised… Read More +

countinue reading

Shardul Amarchand Mangaldas & Co. Advises Vee Healthtek and founders on Strategic Investment by TA Associates

Shardul Amarchand Mangaldas & Co. advised Vee Healthtek , a leading provider of technology enabled solutions and services for healthcare organisations, and its founders on the strategic investment from TA Associates (“TA”).   The transaction team was led by Abhishek Guha, Partner; Jagriti Mohata, Partner and Reshma Simon, Senior Associate. Arjun Perikal, Partner and Shahana… Read More +

countinue reading

Shardul Amarchand Mangaldas & Co. advises Morgan Stanley India Company Private Limited on Qualified Institutions Placement by Zomato Limited

Shardul Amarchand Mangaldas & Co. advised Morgan Stanley India Company Private Limited, the sole Book Running Lead Manager (BRLM), on the Qualified Institutions Placement (QIP) by Zomato Limited. The deal is valued at approximately USD 1 billion.   This is the largest QIP in India in 2024 and marks a significant milestone as the first… Read More +

countinue reading